Commercialization

Regenerative Medicine Foundation

Facilitating the development and cures for diseases through the science of regenerative medicine


Commercialization

GMP

Clinical Trial Design

Clinical trials are conducted to allow safety and efficacy data to be collected for health interventions (e.g., drugs, devices, therapy protocols). These trials can only take place once satisfactory information has been gathered on the quality of the non-clinical safety, and Health Authority/Ethics Committee approval is granted in the country where the trial is taking place.

Good Manufacturing Practices (GMP)

“Good manufacturing practice” or “GMP” is part of a quality system covering the manufacture and testing of active pharmaceutical ingredients, diagnostics, foods, pharmaceutical products, and medical devices. GMPs are guidelines, and in some countries such as the USA regulations, that outline the aspects of production and testing that can impact the quality of a product. Many countries have legislated that pharmaceutical and medical device companies must follow GMP procedures, and have created their own GMP guidelines that correspond with their legislation.

Venture Creation

The Regenerative Medicine Foundation provides unique and custom-designed educational programs and services for researchers, entrepreneurs and investors engaged in the formation of early-stage regenerative medicine companies. Ventures demonstrating a high likelihood of commercial success are eligible to participate in a venture forum at the annual conference that will also feature representation from the international investment community including venture capital and private equity firms.